Riccardo Canevari - 18 Mar 2026 Form 3 Insider Report for Radiopharm Theranostics Ltd (RADX)

Reporting relationship: Managing Director and CEO, Director
Issuer ticker: RADX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 31 Mar 2026, 06:14:24 UTC
Source filing: View source filing
Reporting owner signature: /s/ Riccardo Canevari

Key filing fact

Riccardo Canevari filed Form 3 for Radiopharm Theranostics Ltd (RADX) on 31 Mar 2026.

Key facts

This page summarizes Riccardo Canevari's Form 3 filing for Radiopharm Theranostics Ltd (RADX).
0 reported transactions and 10 derivative rows are listed below.
Accepted by SEC: 31 Mar 2026, 06:14.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002123023 Primary reporting owner

Canevari Riccardo

Relationship: Managing Director and CEO, Director
Address: SUITE 1 LEVEL 3, 62 LYGON STREET, CARLTON SOUTH, VICTORIA, AUSTRALIA
Signature: /s/ Riccardo Canevari
Signature date: 31 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RADX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,679,986
Date: 18 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,225,352
Exercise price: $0.2000

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,875,000
Exercise price: $0.0600

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 8,666,678
Exercise price: $0.6000

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 4,167,946
Exercise price: $0.1700

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,475,384
Exercise price: $0.1120

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,476,127
Exercise price: $0.1120
Footnotes: F1

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 12,000,000
Exercise price: $0.0600

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 18,416,762
Exercise price: $0.0410

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 36,833,524
Exercise price: $0.0410
Footnotes: F2

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 74,338,000
Exercise price: $0.0250
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Granted on December 01, 2023 and will vest on July 1, 2026 provided Mr. Canevari is still a Director on such dates.

Footnote F2

Granted on December 16, 2024. 18,416,762 options will vest on July 1, 2026 and 18,416,762 options will vest on July 1, 2027 provided Mr. Canevari is still a Director on such dates.

Footnote F3

Granted on December 12, 2025. 24,776,855 options will vest on July 1, 2026, 24,776,855 options will vest on July 1, 2027 and 24,784,290 options will vest on July 1, 2028 provided Mr. Canevari is still a Director on such dates.

SEC remarks

All exercise prices are in Australian dollars.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .